CPT in the Media
July 2011
5th July: Professor Donald Singer interviewed by Annie Othen on BBC radio Coventry and Warwickshire about a report in the British Medical Journal by Schmidt and colleagues from Denmark, North Carolina and Boston, USA on 'Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter ..." Professor Singer notes that ‘This large study from Denmark concerns patients prescribed the powerful pain-killer and anti-inflammatory drugs NSAIDs and COX-2 inhibitors. The authors suggest that in the first year on these medicines the serious heart rhythm disorders atrial fibrillation or flutter may occur in an additional 7 out of a thousand patients (10 per 1000 controls vs. 14-17 per 1000 patients on recent treatment with NSAIDs or COS-2 inhibitors). With longer term treatment the reported additional annual increase risk is smaller at up to 2-3 additional patients per 1000 treatment with NSAIDs or COX-2 inhibitors. In this case-control study, the authors aimed to control of confounding reasons for increased risk from the pain-killers. However patients on the drugs were a third more likely to have had known previous heart disease (80%) than in the control population (59%). And no information was available on non-prescribed ‘over-the-counter’ use of drugs. NSAIDs and COX-2 inhibitors should be prescribed based on careful weighing up of their benefits and risks. Patients on these medicines who develop palpitations or other features of heart problems, including shortness of breath or ankle swelling, should consult their GP for advice.’
June 2011
24th June: Professor Donald Singer interviewed by Annie Othen on BBC radio about a report in the Journal of the American Geriatric Society that suggests increased risk of mortality and mental impairment in older people from a wide range of anti-cholinergic and other medicines used in combination. Professor Singer notes that the study relies on events and clinical practice from almost 20 years ago. Since then, there have been many changes in how and what drugs are used. The study was not randomised and therefore open to many types of bias. The researchers cannot exclude the diseases being treated or other non-drug factors as the cause of increased mortality or cognitive impairment reported. If people are concerned about possible heart or other adverse effects from their medicines, they should consult their GP or pharmacist.
March 2011
March issue of parenting journal 'Junior': Professor Donald Singer comments on reported link between paracetamol use and asthma.
January 2011
22nd Jan 2011: Professor Donald Singer interviewed by Malcolm Boyden on BBC Coventry and Warwickshire Radio. From new USA experimental research on effects of caffeine and aspirin-like medicine on 'hangover' Science behind old and new hangover 'cures'
12th Jan 2011. Expert reaction to new research on painkillers and heart attacks/strokes. British Pharmacological Society Members Professor Simon Maxwell, Professor Philip Bath and Professor Donald Singer respond to to BMJ Article, Jan 2011: Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.
Editorial on Poetry and Medicine by Michael Hulse and Donald Singer in January issue of Postgraduate Medical Journal.
November 2010
25.11.10 Professor Singer comments on Daily Express article on history and current benefits and risks of aspirin
22.11.10 Podcast on poetry and medicine with Michael Hulse, Department of English and Comparative Literary Studies, and Donald Singer, Warwick Medical School on the 2011 International Hippocrates Prize for Poetry and Medicine
22.11.10 University of Warwick Press release on the 2011 International Hippocrates Prize for Poetry and Medicine. National poet and outgoing UK family doctor chief to judge 2011 Hippocrates Prize
October 2010
13.10.10 Knowledge Centre interview with Professor Donald Singer by Amy McLeod on Adverse Drug Reactions.
7.10.10 University of Warwick Press Release re Professor Donald Singer on new NICE draft guidance on Alzheimer's disease.
7.10.10 Professor Donald Singer in the Daily Telegraph quoted from his Science and Media Centre response to new NICE draft guidance on Alzheimer's Disease.
'The proposal by NICE to extend its guidance to include access for 3 drugs (donepezil, galantamine and rivastigimine) to patients with much milder disease than previously eligible is excellent news for patients with Alzheimer's disease and their families. It is also very encouraging to have in the guidance a new treatment option (memantine) for patients with more severe disease. People with serious conditions such as Alzheimer's may naturally express concern about how long this has taken. However it is essential that health policy makers have convincing evidence both for effectiveness and risk before making a medicine available to people who could benefit. Consider the recent public concern about regulation of the diabetes drug rosiglitazone, for which an unexpected increase in cardiovascular risk appears to have occurred after it became widely available. It will still be very important to remain vigilant for possible unexpected risks of the Alzheimer's treatments, as these drugs will now be exposed to large numbers of people, who may also be medically more complex, and therefore more at risk of adverse effects, than in the clinical trials on which the NICE guidance has been based.'
There are many causes of dementia other than Alzheimer's. The following paper describes research led by Professor Singer on CADASIL, a genetic disorder for dementia: Hussain, MB, Singhal S, Markus HS, Singer DRJ. 
Abnormal vasoconstrictor responses to angiotensin II and noradrenaline in isolated small arteries from patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 2004; 35:853-8.
September 2010
27.9.10 Professor Donald Singer in live TV interview on BBC Arabic TV Live News on the 26th September Nature Medicine report on a new gene abnormality in migraine with aura - a dominant-negative mutation in the TRESK two-pore domain potassium channel. The normal pain-reducing actions of the channel are lost in the presence even of a single mutant gene. This may both provide a new biomarker to help in treatment choice in migraine and may give clues to development of new treatment approached in selected patients - a further advance in personalising medicines. http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.2216.html
There are multiple genes implicated in migraine, some resulting in complex syndromes. The following paper describes work from our group on disease mechanisms in people with CADASIL, a different, migraine-associated genetic disorder: Hussain, MB, Singhal S, Markus HS, Singer DRJ. Abnormal vasoconstrictor responses to angiotensin II and noradrenaline in isolated small arteries from patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 2004; 35:853-8.
24.9.10 Professor Donald Singer quoted in Daily Mail article
on risks of recreational use of nitrous oxide. With short term and long term recreational use, adverse effects can be troublesome and may be serious. Nitrous oxide is a depressant of the central nervous system. People feel uninhibited when they take it, but large amounts over a short time frame can lead to serious depression of brain function. The problem with nitrous oxide with long term recurrent use is that it interferes with vitamin B12, which is vital for blood cell function. It is also vital for normal nerve and brain function. People at risk from a B12 deficiency can incur damage to their spinal column, nerves and brain …
25.9.10 Comment by Professor Donald Singer on EMA and FDA decisions on the Type 2 diabetes medicine rosiglitazone [Avandia]: Australia Science and Media Centre
24.9.10 Comment at New Zealand Science and Media Centre by Professor Donald Singer on EMA and FDA decisions on the Type 2 diabetes medicine rosiglitazone [Avandia]. People with diabetes are at increased risk of cardiovascular disease. Despite lowering blood sugar, there is increasing concern that the tablet treatment for Type 2 diabetes rosiglitazone may in fact increase risk of heart failure and other serious cardiovascular disorders. Both the European Medicines Agency (EMA) and the US drugs regulator, the Food and Drug Administration (FDA) have today issued important new guidance placing major restrictions on the use of rosiglitazone. The EMA recommended suspension of the drug throughout Europe, either as separate treatment or in combination tablets …
23.9.10 Comment by Professor Donald Singer on EMA and FDA decisions on the Type 2 diabetes medicine rosiglitazone [Avandia]: UK Science and Media Centre:
8.9.10 Jane Dutton interviews Professor Donald Singer on @AJEnglish TV News on cardiovascular risks of anti-diabetic drug rosiglitazone [Avandia].
6.9.10 Jon Snow interviews Professor Donald Singer on Channel 4 News on cardiac risks of the anti-diabetic drug rosiglitazone [Avandia] and roles of the MHRA. See related Owen Bowcott Guardian artlcle 'Diabetes drug available on NHS months after experts call for withdrawal' and BMJ Feature on rosiglitazone by Deborah Cohen.
9. 10 Men's Health - Donald Singer on risks of abnormal sleep patterns and potential effects of Orexins on sleep behaviour.
August 2010
The Strad: 'the taboo tablet' Beta-blocker use by musicians discussed by Professor Donald Singer, University of Warwick and Nick Roberts, Coull Quartet cellist.
BBC 3 Counties Radio: The end of antibiotics? Is the era of antibiotics nearly over? Listen to Professor Donald Singer's interview on BBC Three Counties Radio. See related article by Guardian Health Editor Sarah Boseleypublished 12th August 2010: We have a window of maybe 10 years.
July 2010
22.7.10 BPS Podcast by Professor Donald Singer with Professor Michael Mulvaney (Aarhus, Denmark), Secretary-General of WorldPharma 2010 - attended by ~3200 delegates from 81 countries.
22.7.10 BPS Podcast by Professor Donald Singer with researchers at Copenhagen WorldPharma 2010: Ricardo Pardo, Barcelona on gender and MDMA (ecstacy); Dongying Zhang, Tokohu, Sendai on novel anti-tussive; Fatemeh Rezania, Teheran on lithium-cannabinoid interactions; Doreen Wittkopf, Leipzig on platelet P2Y2 ADP receptor modulation; David Thal, Michigan on novel GPCR kinase 2 modulators; Jenny Svard, Dublin on hepatic effects of anti-HIV retrovirals; Dragana Stankovic, Bosnia-Herzegovina on potassium channel openers.
20.7.10 WorldPharma2010 BPS podcast by Professor Donald Singer with Professor Clifford Woolf, Boston Children's Hospital and Harvard Medical School, on the future of pain relief without numbness or paralysis, based on a targeted TRPV1 receptor strategy http://bit.ly/1gnvzf
19.7.10 BPS Podcasts with researchers at Copenhagen WorldPharma 2010: Berit Jensen [Warfarin monitoring; Christchurch, New Zealand], Elina Skapara [novel drug interaction to improve glucose control; Latvia], Maribel Soto-Nunez, [coumarin metabolite with promising selective anti-cancer effects; Mexico].
19.7.10 WorldPharma2010 BPS podcast by Professor Donald Singer with Professor Richard Williams, Kennedy Institute London, on TNF-alpha, the first biological treatment for rheumatoid disease.
19.7.10 BPS Podcasts with young researchers at Copenhagen WorldPharma2010: Danijela Gnjidic [reducing overtreatment in elderly; Sydney], Linda Klumpers [functional MRI to assess brain network effects of THC; Leiden], Kevin Robillard [modulators of GI absorption of anti-HIV medicines; Toronto], Kate Casey-Green [Chemical Genomics; Warwick].
April 2010
10.4.10 Winners of 2010 Hippocrates Prize awards announced.
13.4.10 BMJ News. 2010;340:c2023 Winning NHS poem takes a doctor's life as its inspiration doi:10.1136/bmj.c2023
15.4.10 Warwick blog re awards symposium
March 2010
27.03.10 The Times Genetic test could match mentally ill patients with the best drug
20.3.10 Lancet article on Poetry and Medicine
22.3.10 Press release 6 finalists shortlisted for new international poetry and medicine prize
23.3.10 Radio 4 Today Interview with John Humphrys
23.3.10 BBC World Service Newshour Interview with Claire Bolderson
24.3.10 The Independent on the Prize Shortlist - 'Verse that will make you feel better'
February 2010
11.02.10 BBC Focus article: 'Does alcohol interact with antibiotics?'
January 2010
14.01.10 BBC Coventry and Warwickshire radio - Donald Singer interviewed on poetry and medicine and the International Hippocrates Prize by Mark Powlett
December 2009
3.12.09 Treatment of flu: New Scientist and oseltamivir. Comment on BMJ paper on meta-analysis of effects of oseltamivir (Tamiflu) BMJ, DOI: 10.1136/bmj.b5106
21.12.09 BBC Coventry and Warwickshire International Hippocrates Prize for Poetry and Medicine
November 2009
26.11.09 New International Hippocrates Prize for Poetry and Medicine
26.11.09 Podcast on poetry and medicine Michael Hulse with Donald Singer
October 2009
12.10.09 Reuters: Going back to the future in personalised medicines
12.10.09 Guardian: Going back to the future in personalised medicines
September 2009
22.09.09 - Cardiovascular Drug Discovery Webcast - Professor Donald Singer, University of Warwick
July 2009
Podcast Interview with Professor Garret Fitzgerald by Prof Tony Harmar and Prof Donald Singer. Recorded at the British Pharmacological Society Summer Meeting 2009 in Edinburgh, where Professor Fitzgerald gave the talk entitled: 'Peripheral Clocks in Cardiovascular & Metabolic Function'.
Sat 10th April - 2010 International Hippocrates Prize Awards for Poetry and Medicine
A new annual Prize for poetry and medicine
There were almost 1700 entries from 31 countries from Canada to Colombia and from Fiji to France and Finland
Awards were announced on Saturday 10th April, 2010 during the International Symposium on Poetry and Medicine at Warwick Arts Centre.
See Hippocrates Poetry website for:
- top 6 awards
- top 20 commended NHS-related entries and top 20 commended Open international entries
- top 300 entries
Poetry and Medicine Press, Radio and Publication links
- 26.11.09 New International Hippocrates Prize for Poetry and Medicine 10th April 2010
- 26.11.09 Podcast on poetry and medicine Michael Hulse with Donald Singer
- 21.12.09 BBC Coventry and Warwickshire International Hippocrates Prize for Poetry and Medicine
- 14.01.10 BBC Coventry and Warwickshire radio - Donald Singer interviewed on poetry and medicine and the International Hippocrates Prize by Mark Powlett
- 20.3.10 Lancet article on Poetry and Medicine
- 22.3.10 Press release 6 finalists shortlisted for new international poetry and medicine prize
- 23.3.10 Radio 4 Today Interview with John Humphrys
- 23.3.10 BBC World Service Newshour Interview with Claire Bolderson
- 24.3.10 The Independent on the Prize Shortlist - 'Verse that will make you feel better'
- 10.4.10 Winners of 2010 Hippocrates Prize awards announced.
- 13.4.10 BMJ News. 2010;340:c2023 Winning NHS poem takes a doctor's life as its inspiration doi:10.1136/bmj.c2023
- 15.4.10 Warwick blog re awards symposium
CPT Newsletters
Newsletter 1 - November 2005
Newsletter 2 - February 2006
Newsletter 3 - July 2006
Newsletter 4 - December 2006
Newsletter 5 - February 2007
Newsletter 6 - July 2007
Newsletter 7 - August 2007
Newsletter 8 - December 2007
Newsletter 9 - August 2008
Newsletter 10 - November 2008
Newsletter 11 - December 2008
Newletter 12 - April 2009
Podcasts
- 17.8.10 Is the era of antibiotics nearly over? Listen to Professor Donald Singer's interview on BBC Three Counties Radio. See related article by Guardian Health Editor Sarah Boseley published 12th August 2010: We have a window of maybe 10 years.
- 22.7.10 BPS Podcast by Professor Donald Singer with Professor Michael Mulvaney (Aarhus, Denmark), Secretary-General of WorldPharma 2010 - attended by ~3200 delegates from 81 countries.
- 22.7.10 BPS Podcast by Professor Donald Singer with researchers at Copenhagen WorldPharma 2010: Ricardo Pardo, Barcelona on gender and MDMA (ecstacy); Dongying Zhang, Tokohu, Sendai on novel anti-tussive; Fatemeh Rezania, Teheran on lithium-cannabinoid interactions; Doreen Wittkopf, Leipzig on platelet P2Y2 ADP receptor modulation; David Thal, Michigan on novel GPCR kinase 2 modulators; Jenny Svard, Dublin on hepatic effects of anti-HIV retrovirals; Dragana Stankovic, Bosnia-Herzegovina on potassium channel openers.
- 20.7.10 WorldPharma2010 BPS podcast by Professor Donald Singer with Professor Clifford Woolf, Boston Children's Hospital and Harvard Medical School, on the future of pain relief without numbness or paralysis, based on a targeted TRPV1 receptor strategy http://bit.ly/1gnvzf
- 19.7.10 BPS Podcasts with researchers at Copenhagen WorldPharma 2010: Berit Jensen [Warfarin monitoring; Christchurch, New Zealand], Elina Skapara [novel drug interaction to improve glucose control; Latvia], Maribel Soto-Nunez, [coumarin metabolite with promising selective anti-cancer effects; Mexico].
- 19.7.10 WorldPharma2010 BPS podcast by Professor Donald Singer with Professor Richard Williams, Kennedy Institute London, on TNF-alpha, the first biological treatment for rheumatoid disease.
- 19.7.10 BPS Podcasts with young researchers at Copenhagen WorldPharma2010: Danijela Gnjidic [reducing overtreatment in elderly; Sydney], Linda Klumpers [functional MRI to assess brain network effects of THC; Leiden], Kevin Robillard [modulators of GI absorption of anti-HIV medicines; Toronto], Kate Casey-Green [Chemical Genomics; Warwick].
- 23.3.10 Radio 4 Today Interview with John Humphrys
- 23.3.10 BBC World Service Newshour Interview with Claire Bolderson
- January 14th 2010 - Professor Donald Singer interviewed on poetry and medicine and the International Hippocrates Prize by Mark Powlett on BBC Coventry and Warwickshire radio.
- November 26th 2009 - Podcast on poetry and medicine Michael Hulse with Donald Singer
- September 22nd 2009 - Cardiovascular Drug Discovery Webcast - Professor Donald Singer, University of Warwick
- July 2009 - Podcast Interview with Professor Garret Fitzgerald by Prof Tony Harmar and Prof Donald Singer. Recorded at the British Pharmacological Society Summer Meeting 2009 in Edinburgh, where Professor Fitzgerald gave the talk entitled: 'Peripheral Clocks in Cardiovascular & Metabolic Function'.
- December 2008 Podcast Interview with Prof Munir Pirmohamed by Prof Donald Singer. This interview took place at the BPS Winter Meeting in Brighton, December 2008, where Prof Pirmohamed gave the talk entitled: 'Warfarin pharmacogenetics: ready for clinical application?'
- December 2008 - Anabolic Drugs in Sport
Podcast Interview with Dr Andrew Kicman and Prof Donald Singer. Dr Andrew Kicman gave the Tocris Lecture on Anabolic Drugs in Sport during the Winter Meeting of the British Pharmacological Society in Brighton, December 2008 - November 2008 - Clinical Pharmacology Colloquium Autumn Meeting, University of Warwick: Professor Philip Routledge on origins and current role of the CPC
- May 2008 - Rational prescribing. Dr Jeffrey Aronson with Professor Donald Singer.
Podcast Interview took place at the British Pharmacology Society & Royal College of Physicians Joint Symposium on Rational Prescribing, Royal College of Physicians, London. - May 2008 - Rational Prescribing. Professor Robin Ferner with Professor Donald Singer. This interview took place at the British Pharmacology Society & Royal College of Physicians Joint Symposium on Rational Prescribing, Royal College of Physicians, London.
- May 2008 - Professor Colin Baigent with Professor Donald Singer on Clinical Trials and prescribing decisions
Podcast Interview at British Pharmacology Society & Royal College of Physicians Joint Symposium on Rational Prescribing, Royal College of Physicians, London. - March 2008 - Podcast Interview at British Pharmacology Society Focused Meeting on High Throughput Pharmacology: Interview with
- Dr Martin Stoeter, Dresden Max Planck Institute of Molecular Cell Biology and Genetics on 'Application of siRNAs to High Throughput Analyses' Transcript
- March 2008 - University of Warwick podcast competition
- December 2007 - British Pharmacology Society Winter Conference - JRVane Medal Lecture: Podcast Interview with Professor Humphrey Rang, FRS: Drugs, Medicines and Society: Pharmacology in the Modern World
- December 2007 - British Pharmacology Society Winter Conference: Podcast Interview with Professor Rod Flower, FRS: Lifestyle drugs: pharmacology and the social agenda
- March 2007: University of Warwick podcast competition: 'Perspectives on conventional and alternative therapies'
- March 2007: Interview with Carl Rose: Community Pharmacy Cardiovascular Health Initiative
- July 2006: Margaret Thorogood, Professor of Epidemiology and Chris Bridle, Senior Lecturer in Health Psychology at Warwick Medical School discuss the impact of pharmacogenetics on pharmacovigilance with Professor Ralph Edwards, WHO Monitoring Centre, Uppsala, Dr Duncan Hale, Pharmacogenetics Division, Pfizer, Dr Robin Ferner, Director of the West Midlands Adverse Drug Reaction Monitoring Centre, Birmingham Genetic testing and pharmacovigilance
- July 2006: Dr Duncan McHale, Senior Director and Head of Molecular Profiling, Pharmacogenetics Division, Pfizer and Dr Kevin Cheeseman, Director of the Discovery Medicine and Epidemiology Section of AstraZeneca Research and Development discuss the potential impact of pharmacogenetics on drug development and safety. Potential impact of pharmacogenetics on drug development and safety
- July 2006: Magnus Ingelman-Sundberg, Professor in the Department of Pharmacology and Physiology at the Karolinska Institute in Stockholm, discusses pharmacogenetics of inter-individual and geographical variability in genes which regulate how drugs are activated or cleared by the body by the important cytochrome P450 (CYP) family of liver enzymes. The right medicine and the right dose for all?
- July 2006: John Hearn, Pro-Vice Chancellor and Professor of Physiology, University of Sydney describes AC21 and discusses the potential and risks of stem cell treatment. Stem Cell therapy - potential and risks
- July 2006: Professor Jan Dumanski, molecular geneticist at the University of Birmingham, Alabama, USA and at the University of Uppsala, Sweden, discusses how gene copy number (CNV or copy number variability) can play a major role in diseases such as cancer and HIV, and in explaining drug responsiveness and adverse effect profiles. Gene dose, cancer, HIV and drug discovery
- Research Festival Podcasts & Media Links
Personalising Medicine
Dealing with stress
- 22.7.10 The Strad: 'the taboo tablet' Beta-blocker use by musicians.
Poetry and Medicine
- 26.11.09 International Symposium on Poetry and Medicine 10th April 2010
- 26.11.09 Podcast on poetry and medicine Michael Hulse with Donald Singer
- 21.12.09 BBC Coventry and Warwickshire International Hippocrates Prize for Poetry and Medicine
- 14.01.10 BBC Coventry and Warwickshire radio - Donald Singer interviewed on poetry and medicine and the International Hippocrates Prize by Mark Powlett
- 20.3.10 Lancet article on Poetry and Medicine
- 22.3.10 Press release 6 finalists shortlisted for new international poetry and medicine prize
- 23.3.10 Radio 4 Today Interview with John Humphrys
- 23.3.10 BBC World Service Newshour Interview with Claire Bolderson
- 24.3.10 The Independent on the Prize Shortlist - 'Verse that will make you feel better'
Treating Infections
- 17.8.10 Is the era of antibiotics nearly over? Listen to Professor Donald Singer's interview on BBC Three Counties Radio.
See related article published 12th August 2010 in The Guardian: We have a window of maybe 10 years.
- 11.02.10 BBC Focus article on 'Does alcohol interact with antibiotics?'
- 3.12.09 Treatment of flu: New Scientist and oseltamivir. Comment on BMJ paper on meta-analysis of effects of oseltamivir (Tamiflu) BMJ, DOI: 10.1136/bmj.b5106
Impact of genetic testing:
- The Times: 27.03.10 Genetic test could match mentally ill patients with the best drug
- Reuters: 12.10.09 Going back to the future in personalised medicines
- Guardian: 12.10.09 Going back to the future in personalised medicines
Adverse drug reactions and safety in medicine use
- March 2010: Risks of borrowing tablets
- 17.3.08 : Comments in Nature on a study reporting that 3% of all deaths in Sweden seem to be caused by adverse reactions to medical drugs. Wester, K. et al . Br. J. Clin. Pharmacol. 2008;65:573-579.
- 17.3.08 Pharmalot - with additional notes and comment
Hazards of nitrous oxide
- - Times 26.11.05
- - Sunday Times 4.2.07
- - LOOK (IPC) 5.3.07
- - ITV News 26.4.07
- - TM magazine
- - 'Legal highs' BBC website 5.08.09 weblink
How to be healthy - ideas, hopes and realities
- September 2010 Men's Health article on 'Orexins and sleep behaviour?'
- University challenges local schools to get healthy!
- Effects of anti-oxidant supplements Saga radio
- 15.6.07 Interview on BBC Coventry & Warwickshire Radio: 'How healthy are 'healthy drinks?' See FAQ - for more information.
High blood pressure
- 17.5.07 2007 World Hypertension Day press release
- 26.3.07 Touch FM Radio interview
- 26.3.07 BBC Coventry & Warwickshire Radio
- 23.3.07 Coventry Evening Telegraph
- 29.3.07 Coventry Observer
- Reducing risks of inherited stroke in young people
European Hypertension Society award of Centre of Excellence
The Centre of Excellence in Hypertension and Cardio-Metabolic Research was launched on Friday 3rd October 2008 at the Clinical Sciences Building on the University Hospital Campus in Coventry,with the participation of Professor Stuart Palmer, Deputy Vice-Chancellor of the University of Warwick, Professor Yvonne Carter, Pro-Vice-Chancellor and Dean of Warwick Medical School and Professor Gordon McInnes [Glasgow], President of the British Hypertension Society.
Health, art and science:
occasional blog on medical matters
Pocket Prescriber now also available on skyscape for mobile devices and desktops
2010 International Hippocrates Awards for Poetry and Medicine
Judges: James Naughtie, Dannie Abse, Sir Bruce Keogh
Winners: Alex Josephy, Pauline Stainer, Edward Picot, Wendy French, Siân Hughes
Organisers: Michael Hulse, Donald Singer
Professor Donald Singer, Warwick;
Professor Gordon McInnes, President, British Hypertension Society;
Professor Franco Cappuccio, Warwick
